About Islet cell autoantigen 1
Islet cell autoantigen 1 (ICA1) is a protein
from Homo sapiens identified by UniProt accession
Q05084, 483 residues long.
MolForge cross-references it against 0 known binders and
77 disease associations.
Target properties
| Protein name | Islet cell autoantigen 1 |
| UniProt accession | Q05084 |
| Gene | ICA1 |
| Organism | Homo sapiens |
| Length | 483 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (77)
Diseases linked to this target (Open Targets).
- alkaline phosphatase measurement · score 0.32
- protein measurement · score 0.32
- serum gamma-glutamyl transferase measurement · score 0.30
- self reported educational attainment · score 0.27
- intraocular pressure measurement · score 0.22
- schizophrenia · score 0.05
- intelligence · score 0.05
- autoimmune disease · score 0.04
- hepatorenocardiac degenerative fibrosis · score 0.04
- kidney disease · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q05084-F1 | alphafold | PREDICTED | 69.81 | — |
Amino-acid sequence (483 residues)
MSGHKCSYPW DLQDRYAQDK SVVNKMQQKY WETKQAFIKA TGKKEDEHVV ASDADLDAKL ELFHSIQRTC LDLSKAIVLY QKRICFLSQE ENELGKFLRS QGFQDKTRAG KMMQATGKAL CFSSQQRLAL RNPLCRFHQE VETFRHRAIS DTWLTVNRME QCRTEYRGAL LWMKDVSQEL DPDLYKQMEK FRKVQTQVRL AKKNFDKLKM DVCQKVDLLG ASRCNLLSHM LATYQTTLLH FWEKTSHTMA AIHESFKGYQ PYEFTTLKSL QDPMKKLVEK EEKKKINQQE STDAAVQEPS QLISLEEENQ RKESSSFKTE DGKSILSALD KGSTHTACSG PIDELLDMKS EEGACLGPVA GTPEPEGADK DDLLLLSEIF NASSLEEGEF SKEWAAVFGD GQVKEPVPTM ALGEPDPKAQ TGSGFLPSQL LDQNMKDLQA SLQEPAKAAS DLTAWFSLFA DLDPLSNPDA VGKTDKEHEL LNA
Explore Islet cell autoantigen 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets